Smith & Nephew

Ticker SN.

Today's data summary

Market open
% change
Price Pence
As of 12:49 21 Mar 2019
Market cap. Pound sterling
13,312.63 million
As of 12:49 21 Mar 2019

Latest updates

Smith & Nephew sinks

The biggest faller in the FTSE 100 is Smith & Nephew.

This follows reports that the manufacturer of medical devices is in talks to buy rival NuVasive in a deal that could be worth $3bn (£2.3bn).

The shares are off 4%.

Revived Smith & Nephew leads FTSE 100

Knee replacement surgery
Getty Images

Orthopaedics group Smith & Nephew is leading the FTSE 100 in early trading after it said that its "established markets" business in areas such as hip and knee implants had improved.

Its share price is up 3.8% at £13.73.

SSE, however, is the morning's biggest faller, down 3.8% to £13.73.

The FTSE 100 gave up early gains to trade 3.02 points lower at 7,655.24.

Engineered ceramics group Vesuvius is the biggest gainer on the FTSE 250, up 9.6% to 639.5p after reporting strong growth in interim revenues.

Aerospace firm Cobham is the biggest faller, down 8.6% at 120.30p followed by shopping centre group Intu whose stock dropped 5.5% to 170p after it announced that its chief executive David Fischel is leaving.

The FTSE 250 is up 4.72 points at 20,758.32.

Results round-up

Getty Images

There are lots of results today, so here's a round-up of the headline figures

  • AstraZenca: Interim revenue down 1% at $10.3bn. Pre-tax profit down 27% at $786m.
  • British American Tobacco: Interim sales up to £11.6bn from £7.4bn. Pre-tax profits up to £3.9bn from £3bn.
  • Smith & Nephew: Interim sales up to $2.4bn from $2.3bn. Pre-tax profit fell to $341m from $383m.
  • National Express: Interim sales up to £1.2bn from £1.1bn. Pre-tax profit rose to £100.7m from £88.9m.
  • Virgin Money: Interim total income rose by 4.8% to £343m. Pre-tax profit rose by 2.7% to £127.2m.